Mitsubishi Tanabe Pharma America’s Post

Is someone you know at risk for kidney disease? Share with them our quick quiz to see if they're in the 33% of adults in the United States at risk for kidney disease. Learn more at MinuteForYourKidneys.org today. #MinuteForYourKidneys

Living with Graft-versus-host disease is a daily challenge that can make people feel alone – but there are resources and a thriving #GVHD community available for support. Learn more at https://lnkd.in/eDXmJmaQ #GVHDDay #GVHDAlliance

Let’s clear up some common misconceptions about Parkinson’s Disease! Knowing the facts can help you better understand and support those affected. #ParkinsonsAwareness #MythBusting #ParkinsonsSupport

It’s #FactDayTuesday! #Fabry disease is a #RareGenetic condition that predominantly affects males. It's crucial to #raiseawareness, promote early detection, and advocate for comprehensive care.  #RareDiseases #MetabolicDisorders

Discover if you're at risk for kidney disease—1 in 3 American adults may be. Take The Rogosin Institute's quiz now to see if you’re at risk: rogosin.org/risk-survey

Every year millions of deaths are caused by heart diseases globally, so let’s pledge to create awareness for better care, prevention and diagnosis of heart-related conditions. Stay healthy, use heart for action and keep the rhythm going. #Worldheartday #UseHeartForAction #heartday

I am privileged that my job allows me to play a small part in campaigning to end one of the world’s oldest and deadliest diseases – malaria. Today is my fifth #worldmalariaday and I’ve seen so much progress, innovation and determination over those five years. I’ve met campaigners, scientists, youth activists, creatives, communicators, entrepreneurs and leaders from around the world who are relentless in their pursuit of #zeromalaria. Yet, here we are. Malaria still kills a child every minute. Every minute. There are reasons to be hopeful. This year countries have begin rolling out a malaria vaccine for young children, with another on the way and more in development. By the end of the year, 20 countries should have a vaccine in their set of tools to tackle malaria. These won’t work on their own and they need to be alongside other tools like nets, spraying, diagnostic tools and more. And there are new innovations in the pipeline such as gene drive and other game-changing ideas. There are some big decisions coming up over the next few years. Alongside countries needing to step up their domestic funding on malaria programmes, we need a fully funding Gavi, the Vaccine Alliance Gavi and The Global Fund to Fight AIDS, Tuberculosis and Malaria. Funding the fight against malaria is critical. The world is complex. Ending malaria is complex. But with the right funding it can be done. So that future generations don’t have to live with malaria. It is time to change the story – fund the fight and achieve #zeromalaria 

Today, 29 February 2024, is Rare Disease Day, dedicated to raising awareness and generating change for the millions of people around the world who suffer from rare diseases and all those who care for them. Read more on www.raredeseaseday.org   #RareDeseaseDay #ClinicalTrial #ClinicalResearch

On Rare Disease Day 2024, N-of-1 Hub stands in solidarity with individuals, families, and communities navigating the challenges of rare diseases. 🌟 We recognize the courage and strength it takes to confront these unique challenges every day. Your resilience inspires us. #raredisease #rarediseaseday #rarediseaseday2024 #rarediseaseawareness #nof1 #clinicaltrials

Women with certain vascular conditions may have different signs and symptoms than men, which can result in delays in diagnosis and potentially worse outcomes. It is vital for women to be aware of their own risk factors, signs, and symptoms, so they can be proactive in the prevention and treatment of vascular disease. Throughout #WomensHistoryMonth be sure to share our #MyHealthMonday posts to help raise awareness about vascular disease. https://ow.ly/nFkx50QKIqc